These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20473748)

  • 21. An inhibitory effect of Berberine from herbal Coptis chinensis Franch on rat detrusor contraction in benign prostatic hyperplasia associated with lower urinary tract symptoms.
    Miao L; Yun X; Yang X; Jia S; Jiao C; Shao R; Hao J; Chang Y; Fan G; Zhang J; Geng Q; Wichai N; Gao X
    J Ethnopharmacol; 2021 Mar; 268():113666. PubMed ID: 33301912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelium as a target of beraprost sodium and fenofibrate for antiatherosclerotic therapy in type 2 diabetes mellitus.
    Otsuki M; Goya K; Kasayama S
    Vasc Health Risk Manag; 2005; 1(3):209-15. PubMed ID: 17319106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting foam cell formation and macrophage polarization in atherosclerosis: The Therapeutic potential of rhubarb.
    Liu X; Wu J; Tian R; Su S; Deng S; Meng X
    Biomed Pharmacother; 2020 Sep; 129():110433. PubMed ID: 32768936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
    Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
    BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Berberine.
    Altern Med Rev; 2000 Apr; 5(2):175-7. PubMed ID: 10767672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pharmacological activity of berberine, a review for liver protection.
    Zhou M; Deng Y; Liu M; Liao L; Dai X; Guo C; Zhao X; He L; Peng C; Li Y
    Eur J Pharmacol; 2021 Jan; 890():173655. PubMed ID: 33068590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of berberine on LPS-induced expression of NF-
    Zhu Z; Xueying L; Chunlin L; Wen X; Rongrong Z; Jing H; Meilan J; Yuwei X; Zili W
    Innate Immun; 2020 Oct; 26(7):627-634. PubMed ID: 32524872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypolipidemic effects of herbal extracts by reduction of adipocyte differentiation, intracellular neutral lipid content, lipolysis, fatty acid exchange and lipid droplet motility.
    Haselgrübler R; Lanzerstorfer P; Röhrl C; Stübl F; Schurr J; Schwarzinger B; Schwarzinger C; Brameshuber M; Wieser S; Winkler SM; Weghuber J
    Sci Rep; 2019 Jul; 9(1):10492. PubMed ID: 31324860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Berberine and inflammatory bowel disease: A concise review.
    Habtemariam S
    Pharmacol Res; 2016 Nov; 113(Pt A):592-599. PubMed ID: 27697643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orally Administered Berberine Modulates Hepatic Lipid Metabolism by Altering Microbial Bile Acid Metabolism and the Intestinal FXR Signaling Pathway.
    Sun R; Yang N; Kong B; Cao B; Feng D; Yu X; Ge C; Huang J; Shen J; Wang P; Feng S; Fei F; Guo J; He J; Aa N; Chen Q; Pan Y; Schumacher JD; Yang CS; Guo GL; Aa J; Wang G
    Mol Pharmacol; 2017 Feb; 91(2):110-122. PubMed ID: 27932556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Promising Anti-atherosclerotic Effect of Berberine: Evidence from In Vitro, In Vivo, and Clinical Studies.
    Fatahian A; Haftcheshmeh SM; Azhdari S; Farshchi HK; Nikfar B; Momtazi-Borojeni AA
    Rev Physiol Biochem Pharmacol; 2020; 178():83-110. PubMed ID: 32789786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative analysis of the anti-inflammatory activity of orengedokuto II: berberine is responsible for the inhibition of NO production.
    Oshima N; Shimizu T; Narukawa Y; Hada N; Kiuchi F
    J Nat Med; 2018 Jun; 72(3):706-714. PubMed ID: 29671127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Berberine acutely inhibits the digestion of maltose in the intestine.
    Li ZQ; Zuo DY; Qie XD; Qi H; Zhao MQ; Wu YL
    J Ethnopharmacol; 2012 Jul; 142(2):474-80. PubMed ID: 22626925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alkaloids in the nature: pharmacological applications in clinical practice of berberine and mate tea.
    Derosa G; Maffioli P
    Curr Top Med Chem; 2014; 14(2):200-6. PubMed ID: 24359201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies.
    Pirillo A; Catapano AL
    Atherosclerosis; 2015 Dec; 243(2):449-61. PubMed ID: 26520899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Berberine for bone regeneration: Therapeutic potential and molecular mechanisms.
    Zhang Y; Ma J; Zhang W
    J Ethnopharmacol; 2021 Sep; 277():114249. PubMed ID: 34058315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multifunctional epiberberine mediates multi-therapeutic effects.
    Liu L; Li J; He Y
    Fitoterapia; 2020 Nov; 147():104771. PubMed ID: 33152460
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury.
    Liang KW; Ting CT; Yin SC; Chen YT; Lin SJ; Liao JK; Hsu SL
    Biochem Pharmacol; 2006 Mar; 71(6):806-17. PubMed ID: 16448624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Berberine inhibits the proliferation and migration of breast cancer ZR-75-30 cells by targeting Ephrin-B2.
    Ma W; Zhu M; Zhang D; Yang L; Yang T; Li X; Zhang Y
    Phytomedicine; 2017 Feb; 25():45-51. PubMed ID: 28190470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of berberine in treatment of rheumatoid arthritis: From multiple targets to therapeutic potential.
    Huang DN; Wu FF; Zhang AH; Sun H; Wang XJ
    Pharmacol Res; 2021 Jul; 169():105667. PubMed ID: 33989762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.